Policy Briefings

Ajinomoto Co. Partners with Astellas Pharma in ADC Licensing Deal for AJICAP® Technology

Ritedose Corporation Receives FDA Approval for Tobramycin Inhalation Solution

Apeloa Pharmaceutical Passes 20th FDA Inspection

Piramal Pharma Solutions Signs MoU with IntoCell to Advance ADC Development

Cellipont Bioservices Collaborates with Ernexa Therapeutics to Advance ERNA-101 into Clinical Manufacturing

Codexis and Nitto Denko Avecia Enter Evaluation Agreement for ECO Synthesis® Manufacturing Platform

IASO Bio Partners with GC Cell to Bring CAR-T Therapy Fucaso to South Korea

Wheeler Bio Partners with Mitsubishi Corporation to Expand CDMO Reach in Asia-Pacific

SK pharmteco and LOTTE BIOLOGICS Sign LOI to Build Integrated ADC CDMO Platform

Lifecore Biomedical Signs New Manufacturing Agreement with Global Pharma Company

Resilience Secures up to $825 Million Financing From Oak Hill Advisors

FUJIFILM Biotechnologies CEO Lars Petersen Named “CEO of the Year” 2025

Curida Partners with Rommelag to Install Europe’s First BFS 550 Line in Norway

Sai Life Sciences Breaks Ground on New CMC Process R&D Centre in Hyderabad

WuXi AppTec Signs Two MoUs to Expand CRDMO Capabilities into Saudi Arabia

Samsung Biologics Announces Q3 2025 Results

Akums Drugs & Pharmaceuticals Breaks Ground on First Overseas Plant in Zambia

Lifecore Biomedical and PolyPeptide Partner to Deliver Integrated Peptide Manufacturing Solutions